Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data, Lancet, vol.369, issue.9556, pp.115-122, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00143965
Congenital toxoplasmosis in France and the United States: one parasite, two diverging approaches, PLoS Negl Trop Dis, vol.11, issue.2, p.5222, 2017. ,
The global burden of congenital toxoplasmosis: a systematic review, Bull World Health Organ, vol.91, issue.7, pp.501-508, 2013. ,
Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis, Emerg Microb Infect, vol.7, issue.1, p.165, 2018. ,
Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States, Pediatrics, vol.139, issue.2, 2017. ,
Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation, Epidemiol Infect, vol.142, issue.8, pp.1661-1670, 2014. ,
, Lancet, vol.363, issue.9425, pp.1965-1976, 2004.
Prenatal education for congenital toxoplasmosis, Cochrane Database Syst Rev, issue.10, p.6171, 2015. ,
Congenital toxoplasmosis in Austria: prenatal screening for prevention is cost-saving, PLoS Negl Trop Dis, vol.11, issue.7, p.5648, 2017. ,
Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years, Clin Infect Dis, vol.56, issue.9, pp.1223-1231, 2013. ,
Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial, Am J Obstet Gynecol, vol.219, issue.4, pp.386-387, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01987714
European Multicentre Study on Congenital T. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii, BJOG, vol.110, issue.2, pp.112-120, 2003. ,
Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid, Europ J Clin Microbiol Infect Dis, vol.21, issue.1, pp.12-16, 2002. ,
Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice, Clin Microbiol Rev, vol.31, issue.4, 2018. ,
Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy, J Perinatol, vol.35, issue.2, pp.90-94, 2015. ,
Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy, Europ J Clin Microbiol Infect Dis, vol.28, issue.3, pp.297-300, 2009. ,
Anti-toxoplasmosis drugs, Curr Opin Investig Drugs, vol.2, issue.10, pp.1368-1374, 2001. ,
Systematic review and meta-analysis of secondary prophylaxis for prevention of HIVrelated toxoplasmic encephalitis relapse using trimethoprim-sulfamethoxazole, Pathog Glob Health, vol.111, issue.6, pp.327-331, 2017. ,
A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprimsulfamethoxazole a real option, HIV Med, vol.18, issue.2, pp.115-124, 2017. ,
A systematic review and meta-analysis of the efficacy of anti-Toxoplasma gondii medicines in humans, PLoS One, vol.10, issue.9, p.138204, 2015. ,
Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis, Acta Trop, vol.185, pp.52-62, 2018. ,
Prenatal diagnosis and treatment of congenital Toxoplasma gondii infections: an experimental study in rhesus monkeys, Eur J Obstet Gynecol Reprod Biol, vol.74, issue.2, pp.183-188, 1997. ,
Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis, Pediatr Infect Dis J, vol.27, issue.1, pp.27-32, 2008. ,
Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year, Am J Obstet Gynecol, vol.180, issue.2, pp.410-415, 1999. ,
Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment, J Pediatr, vol.115, issue.5, pp.765-769, 1989. ,
Congenital toxoplasmosis and prenatal care state programs, BMC Infect Dis, vol.14, p.33, 2014. ,
Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study, PLoS Med, vol.7, issue.10, 2010. ,
Congenital toxoplasmosis in the United States: clinical and serologic findings in infants born to mothers treated during pregnancy, Parasite, vol.26, p.13, 2019. ,
Prevention of mother-to-child transmission of toxoplasmosis: perspectives, Gynecol Obstet Fertil, vol.40, issue.10, pp.591-598, 2012. ,
The placenta: a main role in congenital toxoplasmosis?, Trends Parasitol, vol.27, issue.12, pp.530-536, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00696856
Infection of placental trophoblasts by Toxoplasma gondii, J Infect Dis, vol.188, issue.4, pp.608-616, 2003. ,
Toxoplasma gondii dissemination: a parasite's journey through the infected host, Parasite Immunol, vol.37, issue.3, pp.141-149, 2015. ,
Microbial vertical transmission during human pregnancy, Cell Host Microbe, vol.21, issue.5, pp.561-567, 2017. ,
Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection, J Antimicrob Chemother, vol.22, pp.193-200, 1988. ,
Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests, Eur J Obstet Gynecol Reprod Biol, vol.94, issue.1, pp.37-45, 2001. ,
Value of Toxoplasma gondii detection in one hundred thirty-three placentas for the diagnosis of congenital toxoplasmosis, Pediatr Infect Dis J, vol.26, issue.9, pp.845-846, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00171529
Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis, Eur J Obstet Gynecol Reprod Biol, vol.124, issue.1, pp.3-9, 2006. ,
Congenital toxoplasmosis. A prospective study of 378 pregnancies, N Engl J Med, vol.290, issue.20, pp.1110-1116, 1974. ,
Treatments for toxoplasmosis in pregnancy, Cochrane Database Syst Rev, vol.2, p.1684, 2000. ,
Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy, Ann Pediatr (Paris), vol.31, issue.10, pp.805-809, 1984. ,
Value of prevention of congenital toxoplasmosis, J Fr Ophtalmol, vol.19, issue.5, pp.330-334, 1996. ,
Depistage de la toxoplasmose acquise chez la femme enceinte et de la toxoplasmose congenitale chez le nouveau-ne, Lyon Med, vol.253, pp.33-38, 1985. ,
Prevention of congenital toxoplasmosis. Results at the maternity department of the Hopital Saint-Antoine in 1972, J Gynecol Obstet Biol Reprod (Paris), vol.4, issue.4, pp.557-569, 1975. ,
Congenital toxoplasmosis. Evaluation of the benefit of prenatal therapy, J Gynecol Obstet Biol Reprod (Paris), vol.5, issue.2, pp.265-269, 1976. ,
20 years of screening for toxoplasmosis in pregnant women. The Liege experience in 20,000 pregnancies, Rev Med Liege, vol.45, issue.10, pp.492-497, 1990. ,
Praventive Behandlung der konnatalen Toxoplasmose, 1966. ,
Direct detection of Toxoplasma gondii with polymerase chain reaction in diagnosis of fetal toxoplasma infection, Wien Klin Wochenschr, vol.107, issue.4, pp.137-140, 1995. ,
Prenatal treatment and the risk of congenital toxoplasmosis: preliminary findings from two cohort studies, Pediatr Res, vol.42, 1997. ,
Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol, Epidemiol Infect, vol.127, issue.1, pp.113-120, 2001. ,
Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France, Int J Epidemiol, vol.30, issue.6, pp.1303-1308, 2001. ,
Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis, Int J Epidemiol, vol.30, issue.6, pp.1309-1313, 2001. ,
Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres, Acta Paediatr, vol.94, issue.12, pp.1721-1731, 2005. ,
Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study, Pediatrics, vol.121, issue.5, pp.1215-1222, 2008. ,
Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe, PLoS Negl Trop Dis, vol.2, issue.8, p.277, 2008. ,
Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in Brazil, Int J Infect Dis, vol.16, issue.7, pp.480-486, 1994. ,
Incidence of toxoplasmosis in pregnancy in Campania: a population-based study on screening, treatment, and outcome, Eur J Obstet Gynecol Reprod Biol, vol.240, pp.316-321, 2019. ,
Multidisciplinary approach to congenital Toxoplasma infection: an Italian nationwide survey, New Microbiol, vol.37, issue.3, pp.347-354, 2014. ,
Prenatal diagnosis and treatment of congenital toxoplasmosis: a program of regional surveillance, Minerva Ginecol, vol.52, issue.12, pp.123-134, 2000. ,
The Austrian Toxoplasmosis Register, Clin Infect Dis, vol.60, issue.2, pp.4-10, 1992. ,
Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy, Clin Infect Dis, vol.54, issue.11, pp.1545-1552, 2012. ,
Prevention of congenital toxoplasmosis in Szeged, Hungary Int J Epidemiol, vol.26, issue.2, pp.428-435, 1997. ,
Incidence of symptomatic congenital toxoplasmosis during ten years in a Brazilian Hospital, Pediatr Infect Dis J, vol.35, issue.12, pp.1313-1316, 2016. ,
Screening and prevention of congenital toxoplasmosis: an effectiveness study in a population with a high infection rate, J Matern Fetal Neonatal Med, vol.14, issue.6, pp.398-403, 2003. ,
Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women, Scand J Infect Dis, vol.34, issue.3, pp.201-204, 2002. ,
Outcome of toxoplasmosis acquired during pregnancy following treatment in both pregnancy and early infancy, Fetal Diagn Ther, vol.22, issue.6, pp.444-448, 2007. ,
Role of spiramycin in prevention of fetal toxoplasmosis, J Matern Fetal Neonatal Med, vol.29, issue.13, pp.2073-2076, 2016. ,
, MANDELBROT 9
Systematic screening and treatment of toxoplasmosis during pregnancy: is the glass half full or half empty?, Am J Obstet Gynecol, vol.219, issue.4, pp.315-319, 2018. ,
Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French Multidisciplinary Working Group, Pathogens, vol.8, issue.1, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02070252
Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies, Clin Vaccine Immunol, vol.16, issue.10, pp.1517-1520, 2009. ,
Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid, Obstet Gynecol, vol.115, issue.4, pp.727-733, 2010. ,
Performance of polymerase chain reaction analysis of the amniotic fluid of pregnant women for diagnosis of congenital toxoplasmosis: a systematic review and meta-analysis, PLoS One, vol.11, issue.4, p.149938, 2016. ,
Novel interpretation of molecular diagnosis of congenital toxoplasmosis according to gestational age at the time of maternal infection, J Clin Microbiol, vol.50, issue.12, pp.3944-3951, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02417656
Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis, Memorias Do Instituto Oswaldo Cruz, vol.104, issue.2, pp.389-392, 2009. ,
Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis, J Acquir Immune Defic Syndr, vol.66, issue.5, pp.512-521, 2014. ,
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial, Lancet, vol.393, pp.1428-1439, 2019. ,
Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy, J Antimicrob Chemother, vol.38, issue.1, pp.75-80, 1996. ,
High burden of congenital toxoplasmosis in the United States: the strain hypothesis?, Clin Infect Dis, vol.54, issue.11, pp.1606-1607, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00920832
Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings, J Infect Dis, vol.186, issue.5, pp.684-689, 2002. ,
URL : https://hal.archives-ouvertes.fr/hal-02077073
First Colombian multicentric newborn screening for congenital toxoplasmosis, PLoS Negl Trop Dis, vol.5, issue.5, p.1195, 2011. ,
Recommandation en santé publique: Surveillance serologie toxoplasmose et rubéole durant la grossesse ,
Decline of seroprevalence and incidence of congenital toxoplasmosis despite changing prevention policy-three decades of cord-blood screening in North-Western Switzerland, Pediatr Infect Dis J, vol.37, issue.11, pp.1087-1092, 2018. ,
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study, Clin Infect Dis, vol.42, issue.10, pp.1383-1394, 2006. ,
Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model, PLoS Negl Trop Dis, vol.5, issue.9, p.1333, 2011. ,
Rapid, inexpensive, fingerstick, wholeblood, sensitive, specific, point-of-care test for anti-toxoplasma antibodies, PLoS Neglect Trop Dis, vol.12, issue.8, p.6536, 2018. ,